NOVARTIS CONSUMER HEALTH SA has a total of 171 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 1996. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United Kingdom. Its main competitors in its focus markets pharmaceuticals, medical technology and packaging and shipping are SERRANO GIL DANIEL, EPIGENESIS PHARMACEUTICALS LLC and LEOPOLDO DE JESUS ESPINOSA ABD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 25 | |
#2 | Australia | 20 | |
#3 | United Kingdom | 19 | |
#4 | EPO (European Patent Office) | 17 | |
#5 | Canada | 14 | |
#6 | South Africa | 9 | |
#7 | United States | 8 | |
#8 | China | 6 | |
#9 | Argentina | 5 | |
#10 | Hungary | 4 | |
#11 | Israel | 4 | |
#12 | Poland | 4 | |
#13 | Taiwan | 4 | |
#14 | Brazil | 3 | |
#15 | Czechia | 3 | |
#16 | Hong Kong | 3 | |
#17 | Mexico | 3 | |
#18 | Norway | 3 | |
#19 | Peru | 2 | |
#20 | Austria | 1 | |
#21 | Belgium | 1 | |
#22 | Switzerland | 1 | |
#23 | Cyprus | 1 | |
#24 | Denmark | 1 | |
#25 | Spain | 1 | |
#26 | Finland | 1 | |
#27 | France | 1 | |
#28 | Greece | 1 | |
#29 | Ireland | 1 | |
#30 | Italy | 1 | |
#31 | Luxembourg | 1 | |
#32 | Netherlands | 1 | |
#33 | New Zealand | 1 | |
#34 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Packaging and shipping | |
#4 | Foods and drinks | |
#5 | Machines | |
#6 | Computer technology |
# | Name | Total Patents |
---|---|---|
#1 | Steiger Michel | 24 |
#2 | Ancerewicz Jacek | 23 |
#3 | Schumann Phyllis | 23 |
#4 | Sallin Dominique | 23 |
#5 | Kienzler Jean-Luc | 22 |
#6 | Schmid Beat | 17 |
#7 | Larnier Catherine | 14 |
#8 | Tschollar Werner | 14 |
#9 | Rault Isabelle | 14 |
#10 | Marzano Giovanna | 13 |
Publication | Filing date | Title |
---|---|---|
GB201718368D0 | Novel composition | |
GB201718365D0 | Novel composition | |
GB201718363D0 | Novel composition | |
GB201718367D0 | Novel composition | |
WO2017212422A1 | Topical compositions comprising carbomer for the treatment and prevention of viral infections and allergic conditions | |
WO2016120787A1 | Oral n-acetylcysteine in the treatment of upper respiratory tract infections and symptoms | |
GB201515354D0 | Novel Device | |
US2015265713A1 | Phenylephrine formulations with improved stability | |
EP2480212A1 | Oral pharmaceutical composition comprising diclofenac | |
GB0605997D0 | Containment For Supplying Individual Pouches | |
WO2005079603A1 | Dietary fiber composition | |
WO2005075320A1 | Casing for a blister package | |
EP1667664A1 | Coated tablets of diclofenac | |
AU2004262934A1 | Topical composition comprising terbinafine and hydrocortisone | |
GB0417909D0 | Drop preparations | |
GB0325604D0 | Coated tablets | |
GB0322371D0 | Coated tablets | |
WO2004017998A2 | Topical emulsion- gel composition comprising diclofenac sodium | |
WO2004000272A1 | Nasal compositions comprising a mucopolysaccharide and propylene glycol | |
GB0218994D0 | Oral pharmaceutical compositions |